Irish Medication Safety Network

improve patient safety with medication use

  • Home
  • About Us
    • Who are the IMSN?
    • Attending Members
    • Terms of Reference
  • Publications & Alerts
  • Conference
    • 2025 Kilmainham
    • 2024 Dublin Castle (All-Island)
    • Previous Years
  • Engage with us
  • Members
    Discussion Forum
Select Page

Insulin (Best Practice Guidelines) v2

by IMSN | Jul 8, 2020 | Articles | 0 comments

The US Institute for Safe Medication Practices considers insulin to be one of the top 5 ‘high-alert’ medications i.e. drugs that bear a heightened risk of causing significant patient harm when they are used in error.

IMSN Insulin Best Practice Guidelines March 2020

Recent Posts

  • Medication Safety Bulletins & other published material 2 July 2025
  • World Parkinson’s Day – 11th April 2025 2 April 2025
  • Ground-breaking All-Island Medication Safety Conference to Take Place Amidst Rising Healthcare Challenges 29 November 2024
  • Parkinson’s disease: Reducing harm from medications (Safety Alerts) 11 November 2024
  • Sound Alike Look Alike Drugs (SALADs) 5 November 2024

Every effort has been made to ensure the accuracy of the publications on this website. However, the IMSN cannot accept legal responsibility for any errors or omissions.

  • Facebook
  • Twitter
  • Google
  • RSS

Designed by Elegant Themes | Powered by WordPress